| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 2.290 | 13 | 0 | 25.569 | 62.453 |
| Total Income - EUR | - | - | - | - | 1.029 | 2.380 | 13 | 0 | 26.695 | 62.453 |
| Total Expenses - EUR | - | - | - | - | 5.255 | 7.488 | 10.563 | 10.849 | 20.784 | 22.226 |
| Gross Profit/Loss - EUR | - | - | - | - | -4.226 | -5.109 | -10.550 | -10.849 | 5.911 | 40.227 |
| Net Profit/Loss - EUR | - | - | - | - | -4.226 | -5.109 | -10.550 | -10.849 | 5.646 | 39.451 |
| Employees | - | - | - | - | 0 | 1 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Rejuvenal Labs S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 13.517 | 18.539 | 19.018 | 19.808 | 23.570 | 26.612 |
| Current Assets | - | - | - | - | 14.871 | 17.807 | 18.200 | 34.285 | 42.804 | 43.258 |
| Inventories | - | - | - | - | 5.342 | 9.887 | 9.922 | 20.578 | 24.545 | 29.496 |
| Receivables | - | - | - | - | 3.952 | 5.350 | 6.033 | 10.123 | 15.035 | 10.384 |
| Cash | - | - | - | - | 5.577 | 2.569 | 2.245 | 3.583 | 3.223 | 3.378 |
| Shareholders Funds | - | - | - | - | -4.184 | -9.213 | -19.558 | -30.468 | -24.730 | 14.860 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 32.572 | 45.559 | 56.776 | 84.560 | 91.104 | 58.165 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7211 - 7211" | |||||||||
| CAEN Financial Year |
7211
|
|||||||||
Comments - Rejuvenal Labs S.r.l.